Cargando…

The Case for Abandoning Therapeutic Chelation of Copper Ions in Alzheimer's Disease

The “therapeutic chelation” approach to treating Alzheimer's disease (AD) evolved from the metals hypothesis, with the premise that small molecules can be designed to prevent transition metal-induced amyloid deposition and oxidative stress within the AD brain. Over more than 20 years, countless...

Descripción completa

Detalles Bibliográficos
Autor principal:	Drew, Simon C.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2017
Materias:	Neuroscience
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5455140/ https://www.ncbi.nlm.nih.gov/pubmed/28626387 http://dx.doi.org/10.3389/fnins.2017.00317

Ejemplares similares

Commentary: The Case for Abandoning Therapeutic Chelation of Copper Ions in Alzheimer’s Disease
por: Squitti, Rosanna, et al.
Publicado: (2017)

Exploring Mannosylpurines as Copper Chelators and Cholinesterase Inhibitors with Potential for Alzheimer’s Disease
por: Schino, Ignazio, et al.
Publicado: (2022)

Copper chelation in patients with hypertrophic cardiomyopathy
por: Reid, Anna, et al.
Publicado: (2022)

Alzheimer’s disease causation by copper toxicity and treatment with zinc
por: Brewer, George J.
Publicado: (2014)

The Role of Copper in Tau-Related Pathology in Alzheimer’s Disease
por: Zubčić, Klara, et al.
Publicado: (2020)

Role of Copper in the Onset of Alzheimer’s Disease Compared to Other Metals
por: Bagheri, Soghra, et al.
Publicado: (2018)

Iron chelators as a therapeutic option for Alzheimer’s disease—A mini-review
por: Schreiner, Oliver Daniel, et al.
Publicado: (2023)

Widespread Decreases in Cerebral Copper Are Common to Parkinson's Disease Dementia and Alzheimer's Disease Dementia
por: Scholefield, Melissa, et al.
Publicado: (2021)

Increased Uptake of Chelated Copper Ions by Lolium perenne Attributed to Amplified Membrane and Endodermal Damage
por: Johnson, Anthea, et al.
Publicado: (2015)

Microglia in Alzheimer's Disease: A Role for Ion Channels
por: Thei, Laura, et al.
Publicado: (2018)

Serum Copper, Zinc, and Iron Levels in Patients with Alzheimer's Disease: A Meta-Analysis of Case-Control Studies
por: Li, Dan-Dan, et al.
Publicado: (2017)

Hypopituitarism in Wilson’s disease resolved after copper-chelating therapy
por: Dauth, Nina, et al.
Publicado: (2021)

Ternary Cu(II) Complex with GHK Peptide and Cis-Urocanic Acid as a Potential Physiologically Functional Copper Chelate
por: Bossak-Ahmad, Karolina, et al.
Publicado: (2020)

Current Biomedical Use of Copper Chelation Therapy
por: Baldari, Silvia, et al.
Publicado: (2020)

Distribution in Rat Blood and Brain of TDMQ20, a Copper Chelator Designed as a Drug-Candidate for Alzheimer’s Disease
por: Huang, Lan, et al.
Publicado: (2022)

The Contribution and Therapeutic Potential of Epigenetic Modifications in Alzheimer’s Disease
por: Wood, Ian C.
Publicado: (2018)

Patient Affected by Beta-Propeller Protein-Associated Neurodegeneration: A Therapeutic Attempt with Iron Chelation Therapy
por: Fonderico, Mattia, et al.
Publicado: (2017)

Synergy effects of copper ion in doxorubicin-based chelate prodrug for cancer chemo-chemodynamic combination therapy
por: Zhang, Wen, et al.
Publicado: (2023)

Copper Chelator Induced Efficient Episodic Memory Recovery in a Non-Transgenic Alzheimer’s Mouse Model
por: Ceccom, Johnatan, et al.
Publicado: (2012)

Nanoliposomes as a Therapeutic Tool for Alzheimer’s Disease
por: Ordóñez-Gutiérrez, Lara, et al.
Publicado: (2020)

Pathological BBB Crossing Melanin-Like Nanoparticles as Metal-Ion Chelators and Neuroinflammation Regulators against Alzheimer’s Disease
por: Huang, Qianqian, et al.
Publicado: (2023)

A novel method of rapid detection for heavy metal copper ion via a specific copper chelator bathocuproinedisulfonic acid disodium salt
por: Wang, Yali, et al.
Publicado: (2023)

Chelators for copper radionuclides in positron emission tomography radiopharmaceuticals()
por: Cai, Zhengxin, et al.
Publicado: (2013)

Iron and Copper Intracellular Chelation as an Anticancer Drug Strategy
por: Gaur, Kavita, et al.
Publicado: (2018)

NSAIDs: How they Work and their Prospects as Therapeutics in Alzheimer's Disease
por: Sastre, Magdalena, et al.
Publicado: (2010)

Fluid Biomarkers in Clinical Trials of Alzheimer’s Disease Therapeutics
por: Ritter, Aaron, et al.
Publicado: (2015)

Iron and Alzheimer’s Disease: From Pathogenesis to Therapeutic Implications
por: Liu, Jun-Lin, et al.
Publicado: (2018)

Gamma Oscillations in Alzheimer’s Disease and Their Potential Therapeutic Role
por: Traikapi, Artemis, et al.
Publicado: (2021)

Pyroptosis as a candidate therapeutic target for Alzheimer’s disease
por: Huang, Yuehua, et al.
Publicado: (2022)

Microglia in Alzheimer’s disease: pathogenesis, mechanisms, and therapeutic potentials
por: Miao, Jifei, et al.
Publicado: (2023)

Chelating Agents and the Regulation of Metal Ions
por: Bulman, Robert A.
Publicado: (1994)

Dual-target anti-Alzheimer’s disease agents with both iron ion chelating and monoamine oxidase-B inhibitory activity
por: Mi, Zhisheng, et al.
Publicado: (2019)

Copper Toxicity Links to Pathogenesis of Alzheimer’s Disease and Therapeutics Approaches
por: Ejaz, Hafza Wajeeha, et al.
Publicado: (2020)

New Therapeutic Approaches for Alzheimer’s Disease and Cerebral Amyloid Angiopathy
por: Saito, Satoshi, et al.
Publicado: (2014)

Autophagy and Alzheimer’s Disease: From Molecular Mechanisms to Therapeutic Implications
por: Uddin, Md. Sahab, et al.
Publicado: (2018)

APOE and Alzheimer’s Disease: From Lipid Transport to Physiopathology and Therapeutics
por: Husain, Mohammed Amir, et al.
Publicado: (2021)

Therapeutic properties of multi-cannabinoid treatment strategies for Alzheimer’s disease
por: Coles, Madilyn, et al.
Publicado: (2022)

Editorial: Mechanisms, markers and therapeutics of synaptic pathology in Alzheimer's disease
por: Metaxas, Athanasios, et al.
Publicado: (2022)

Abandoning Eugenics and the QALY
por: Langley, Paul C
Publicado: (2021)

The Extracellular Domain of Human High Affinity Copper Transporter (hNdCTR1), Synthesized by E. coli Cells, Chelates Silver and Copper Ions In Vivo
por: Sankova, Tatiana P., et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_6j2me1t3vbfu9g4tda94r9bobh